K2X Technology & Life Science, Inc. Share Price
Equities
KBPH
US5015722003
Financial & Commodity Market Operators
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1 USD | -45.65% | -.--% | -.--% |
Sales 2020 | 0.01 1.18 | Sales 2021 | - | Capitalization | 18.62M 1.55B |
---|---|---|---|---|---|
Net income 2020 | - 0 | Net income 2021 | - 0 | EV / Sales 2020 | 92,61,38,940 x |
Net cash position 2020 | 28.01K 2.33M | Net cash position 2021 | 8.26M 688M | EV / Sales 2021 | - |
P/E ratio 2020 |
-17
x | P/E ratio 2021 |
95
x | Employees | 1 |
Yield 2020 * |
-
| Yield 2021 |
-
| Free-Float | 53.62% |
1 day | -45.65% |
Managers | Title | Age | Since |
---|---|---|---|
Paul Russo
CEO | Chief Executive Officer | 81 | 05/99/05 |
Director of Finance/CFO | 75 | 15/18/15 | |
Investor Relations Contact | - | 01/19/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Paul Russo
CEO | Chief Executive Officer | 81 | 05/99/05 |
Peter Staple
BRD | Director/Board Member | 72 | 08/21/08 |
Jon Saxe
BRD | Director/Board Member | 88 | 08/21/08 |
1st Jan change | Capi. | |
---|---|---|
-.--% | 16.33M | |
+6.82% | 78.64B | |
+0.67% | 62B | |
+10.07% | 47.32B | |
+6.69% | 35.88B | |
-21.51% | 12.38B | |
+16.72% | 10.12B | |
-27.46% | 8.21B | |
+14.38% | 7.38B | |
-6.00% | 7.3B |
- Stock Market
- Equities
- KBPH Stock